ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Colorado » Internal Medicine

Top Internal Medicine Prescribers in Colorado

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
REBECCA HANRATTY MD

Internal Medicine

12,106

$505K

551
276 are 65+

24%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 9%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $56

JAMES STJERNHOLM M.D.

Internal Medicine

12,078

$646K

469
430 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

23%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $56

ROMANO ABUABA MD

Internal Medicine

12,023

$716K

347
252 are 65+

29%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $56

LAWRENCE ROTH MD

Internal Medicine

11,827

$455K

840
779 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $56

PANKAJ NASHIKKAR MD

Internal Medicine

11,785

$659K

388
291 are 65+

26%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $56

DANIEL ZENK MD

Internal Medicine

11,755

$558K

832
732 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $56

MICHAEL RAGSDALE MD

Internal Medicine

11,750

$619K

349
303 are 65+

22%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $56

SWARUPA REDDY MD

Internal Medicine

11,723

$407K

707
644 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$35
Average prescription price

Avg: $56

JONATHAN LEE M D

Internal Medicine

11,640

$462K

981
872 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $56

DENNIS CHANNEL MD

Internal Medicine

11,534

$472K

643
578 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $56

MICHAEL RANDLE MD

Internal Medicine

11,364

$522K

579
494 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

4%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $56

NORSE BEAR M.D.

Internal Medicine

11,305

$471K

814
751 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $56

IAN ROBERTSON MD

Internal Medicine

11,273

$435K

674
636 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$39
Average prescription price

Avg: $56

JOHN EBENS MD

Internal Medicine

11,172

$525K

616
524 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $56

TERRENCE BOLAND MD

Internal Medicine

10,960

$467K

736
674 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $56

HEATHER SHULL M.D.

Internal Medicine

10,938

$403K

704
637 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $56

DANIEL WITTEN MD

Internal Medicine

10,934

$905K

251
221 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $56

JOHN MAHONEY M.D.

Internal Medicine

10,809

$413K

626
579 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $56

JAMES REPPERT M.D.

Internal Medicine

10,778

$388K

384
360 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$36
Average prescription price

Avg: $56

CHERRY DELOSREYES MD

Internal Medicine

10,744

$715K

409
325 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $56

ROBERT SPEES MD

Internal Medicine

10,727

$739K

481
406 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $56

LAURENCE JENSEN MD

Internal Medicine

10,658

$694K

377
345 are 65+

17%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $56

LEV ASHEROV MD

Internal Medicine

10,625

$548K

493
364 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $56

SCOTT SUTTON MD

Internal Medicine

10,583

$428K

477
197 are 65+

24%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $56

DAVID MCCARTY DO

Internal Medicine

10,538

$590K

460
382 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

14%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank